Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Nesiritide (Natrecor) Peptide
Recombinant BNP for acute decompensated heart failure.
What is Nesiritide (Natrecor)?
Nesiritide (Natrecor) is a natriuretic peptide · cardiology peptide studied for acute decompensated heart failure. Below is an educational overview of Nesiritide (Natrecor) peptide benefits, mechanism, common research protocols, dosage references, and known side effects.
Plain-Language Label Highlights
Brand names: Natrecor
Acutely decompensated heart failure with shortness of breath at rest (hospital use only).
An IV recombinant version of a natural heart hormone (BNP) that relaxes blood vessels and reduces fluid overload.
- •Low blood pressure
- •Headache
- •Nausea
- •Back pain
- •Significant hypotension
- •Worsening kidney function
- •Cardiogenic shock
- •Systolic blood pressure <90 mmHg
Educational summary of the FDA prescribing information. Not a substitute for the full label or medical advice. Always discuss with a licensed prescriber.
Nesiritide (Natrecor) Mechanism of Action
Recombinant human B-type natriuretic peptide that binds natriuretic peptide receptors to cause vasodilation, natriuresis, and reduction of preload/afterload in decompensated heart failure.
Nesiritide (Natrecor) Research Areas & Benefits
Nesiritide (Natrecor) Dosage & Common Research Protocols
2 mcg/kg IV bolus + 0.01 mcg/kg/min infusion.
Protocols summarized for educational reference from published research. Not dosing guidance.
Nesiritide (Natrecor) Studies & Cited Research
ASCEND-HF trial
Modest dyspnea improvement; no mortality benefit.
Why we trust this source: Published in a peer-reviewed scientific journal with editorial and reviewer oversight.
Citations are linked to PubMed, Google Scholar, and Crossref searches so you can verify the source independently. All references are reviewed during our editorial passes (last reviewed June 1, 2026).
Nesiritide (Natrecor) Side Effects & Safety Considerations
- •FDA-approved.
- •Hypotension common; renal monitoring needed.
Explore more peptides
Educational Information Only — Not Medical Advice
All content on this page is for educational and informational purposes only. It is not medical advice, diagnosis, or treatment. We make no claims that any peptide can diagnose, treat, cure, or prevent any disease. Peptides discussed are not FDA-approved for the indications listed unless explicitly stated otherwise.
Always consult a licensed healthcare provider before beginning any wellness protocol. Statements have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability, eligibility, and pricing may vary.
Ask the Library
Ask anything about peptides — answers come from our curated reference library with citations.